| Drug Name |
Methoxy polyethylene glycol-epoetin beta |
| Drug ID |
BADD_D01421 |
| Description |
Methoxy polyethylene glycol-epoetin beta is a chemically synthesised Erythropoiesis Stimulating Agent (ESA) with a longer half-life than erythropoietin. ESA is used to increase synthesis of red blood cells to treat chronic kidney disease associated anemia. |
| Indications and Usage |
For the treatment of patients with anaemia associated with chronic kidney disease. Not a substitute for RBC transfusion if immediate correction of anemia is required. |
| Marketing Status |
approved |
| ATC Code |
B03XA03 |
| DrugBank ID |
DB09107
|
| KEGG ID |
D09998
|
| MeSH ID |
C508420
|
| PubChem ID |
Not Available
|
| TTD Drug ID |
D0K3XP
|
| NDC Product Code |
59353-407; 59353-408; 59353-401; 59353-405; 59353-403; 59353-404; 59353-400; 59353-402; 59353-406 |
| UNII |
LR3UXN0193
|
| Synonyms |
continuous erythropoietin receptor activator | CERA (erythropoietin receptor activator) | methoxy polyethylene glycol-epoetin beta | epoetin beta pegol | Mircera |
